Real-World Efficacy and Safety of Tafluprost in Primary Open-Angle Glaucoma Patients with Corneal Disorders: A Taiwan Experience

PURPOSE: To investigate the efficacy and safety of switching to 0.0015% tafluprost ophthalmic solution with reduced benzalkonium chloride (BAK) on primary open-angle glaucoma (POAG) patients with corneal disorders under 0.005% latanoprost treatment. Material and Methods. This was a single-arm, open-...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ju-Kuo, Wei, Fu-Tsung, Liu, Yi-Chun, Yen, Yung-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637041/
https://www.ncbi.nlm.nih.gov/pubmed/36345493
http://dx.doi.org/10.1155/2022/4885485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637041/
https://www.ncbi.nlm.nih.gov/pubmed/36345493
http://dx.doi.org/10.1155/2022/4885485

Ejemplares similares